^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    177Lu-LNC1003

    i
    Other names: 177Lu-LNC1003, 177Lu-PSMA-EB-01
    Associations

    News

    Trials
    Company:
    Dongcheng Pharma
    Drug class:
    Ionizing radiation emitter, PSMA inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov)
    P=N/A, N=9, Recruiting, Peking Union Medical College Hospital
    New trial • Metastases
    |
    FOLH1 (Folate hydrolase 1)
    |
    FOLH1 expression • FOLH1 overexpression
    |
    177Lu-LNC1003